Tumor Protein (TP)-p53 Members as Regulators of Autophagy in Tumor Cells upon Marine Drug Exposure
Targeting autophagic pathways might play a critical role in designing novel chemotherapeutic approaches in the treatment of human cancers, and the prevention of tumor-derived chemoresistance. Marine compounds were found to decrease tumor cell growth in vitro and in vivo. Some of them were shown to i...
Main Author: | Edward A. Ratovitski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-08-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/14/8/154 |
Similar Items
-
Tumor protein 53-induced nuclear protein 1 (TP53INP1) enhances p53 function and represses tumorigenesis
by: Jeyran eShahbazi, et al.
Published: (2013-05-01) -
Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
by: Maria Mrakovcic, et al.
Published: (2017-08-01) -
Mutant p53 as a Regulator and Target of Autophagy
by: Yong Shi, et al.
Published: (2021-02-01) -
Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
by: Maria Mrakovcic, et al.
Published: (2018-12-01) -
Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation
by: Shi Yun Yeo, et al.
Published: (2016-03-01)